Evidence map›Paper›PMID 27168335›Full record

ArticlePloS one2016

Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.

Sarah E Wilson, Laura C Rosella, Jun Wang, Nicole Le Saux, Natasha S Crowcroft, Tara Harris, Shelly Bolotin, Shelley L Deeks

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Vaccination as cost-stabilizing health infrastructure: A Canadian perspective.Canadian journal of public health = Revue canadienne de sante publique · 2026
    Article
  4. Epidemiology of norovirus and viral gastroenteritis in Ontario, Canada, 2009-2014.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2021
    Article
  5. Article
  6. The impact of publicly funded rotavirus immunization programs on Canadian children.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2021
    Article
  7. Review
  8. Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. How We Will, Not Whether We Can: Improving Health and Healthcare.Healthcare policy = Politiques de sante · 2017
    Article
  16. Article
  17. The Incidence of Acute Gastrointestinal Illness in Canada, Foodbook Survey 2014-2015.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2017
    Article
  18. Article
  19. Human Vaccines & Immunotherapeutics: News.Human vaccines & immunotherapeutics · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah E WilsonPublic Health Ontario, Toronto, Ontario, Canada.ORCID 0000-0002-8239-0094
Laura C RosellaPublic Health Ontario, Toronto, Ontario, Canada.
Jun WangPublic Health Ontario, Toronto, Ontario, Canada.
Nicole Le SauxDivision of Infectious Disease, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Natasha S CrowcroftPublic Health Ontario, Toronto, Ontario, Canada.
Tara HarrisPublic Health Ontario, Toronto, Ontario, Canada.
Shelly BolotinPublic Health Ontario, Toronto, Ontario, Canada.
Shelley L DeeksPublic Health Ontario, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the direct and indirect population impact of rotavirus (RV) immunization on hospitalizations and emergency department (ED) visits for acute gastroenteritis (AGE) in Ontario before and after the publicly-funded RV immunization program.

methodsAdministrative data was used to identify ED visits and hospitalizations for all Ontarians using ICD-10 codes. We used two outcome definitions: RV-specific AGE (RV-AGE) and codes representing RV-, other viral and cause unspecified AGE ("overall AGE"). The pre-program and public program periods were August 1, 2005 to July 31, 2011; and August 1, 2011 to March 31, 2013, respectively. A negative binominal regression model that included the effect of time was used to calculate rates and rate ratios (RRs) and 95% confidence intervals (CIs) for RV-AGE and overall AGE between periods, after adjusting for age, seasonality and secular trends. Analyses were conducted for all ages combined and age stratified.

resultsRelative to the pre-program period, the adjusted RRs for RV-AGE and overall AGE hospitalizations in the public program period were 0.29 (95%CI: 0.22-0.39) and 0.68 (95%CI: 0.62-0.75), respectively. Significant reductions in RV-AGE hospitalizations were noted overall and for the following age bands: < 12 months, 12-23 months, 24-35 months, 3-4 years, and 5-19 years. Significant declines in overall AGE hospitalizations were observed across all age bands, including older adults > = 65 years (RR 0.80, 95%CI: 0.72-0.90). The program was associated with adjusted RRs of 0.32 (95% CI: 0.20-0.52) for RV-AGE ED visits and 0.90 (95% CI: 0.85-0.96) for overall AGE ED visits.

conclusionsThis large, population-based study provides evidence of the impact of RV vaccine in preventing hospitalizations and ED visits for RV-AGE and overall AGE, including herd effects.

Indexed as

Immunization ProgramsAdolescentAdultAgedChildChild, PreschoolEmergency Service, HospitalFemaleGastroenteritisHospitalizationHumansInfantInfant, NewbornMaleMass VaccinationMiddle AgedRotavirus VaccinesVaccines, Attenuated

Identifiers

PMID27168335
PMCPMC4864308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.